WO2017065596A1 - Calcio soluble estabilizado en polímero catiónico-polímero aniónico y fructanos - Google Patents
Calcio soluble estabilizado en polímero catiónico-polímero aniónico y fructanos Download PDFInfo
- Publication number
- WO2017065596A1 WO2017065596A1 PCT/MX2016/000106 MX2016000106W WO2017065596A1 WO 2017065596 A1 WO2017065596 A1 WO 2017065596A1 MX 2016000106 W MX2016000106 W MX 2016000106W WO 2017065596 A1 WO2017065596 A1 WO 2017065596A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- calcium
- solution
- parts
- fructans
- soluble
- Prior art date
Links
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 title claims abstract description 76
- 239000011575 calcium Substances 0.000 title claims abstract description 76
- 229910052791 calcium Inorganic materials 0.000 title claims abstract description 76
- 229920002670 Fructan Polymers 0.000 title claims description 42
- ZFTFOHBYVDOAMH-XNOIKFDKSA-N (2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-2-(hydroxymethyl)oxolan-2-yl]oxymethyl]-2-(hydroxymethyl)oxolane-2,3,4-triol Chemical class O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(OC[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 ZFTFOHBYVDOAMH-XNOIKFDKSA-N 0.000 title claims description 41
- 229920006317 cationic polymer Polymers 0.000 title claims description 25
- 239000000203 mixture Substances 0.000 claims abstract description 28
- 238000000034 method Methods 0.000 claims abstract description 19
- 238000002360 preparation method Methods 0.000 claims abstract description 9
- 235000013305 food Nutrition 0.000 claims abstract description 7
- 229920001202 Inulin Polymers 0.000 claims description 37
- 229940029339 inulin Drugs 0.000 claims description 37
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 37
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 29
- 229920001661 Chitosan Polymers 0.000 claims description 26
- 244000215068 Acacia senegal Species 0.000 claims description 24
- 229920000084 Gum arabic Polymers 0.000 claims description 24
- 235000010489 acacia gum Nutrition 0.000 claims description 24
- 239000000205 acacia gum Substances 0.000 claims description 24
- 235000019731 tricalcium phosphate Nutrition 0.000 claims description 22
- 239000007787 solid Substances 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 14
- 239000000835 fiber Substances 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 13
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 11
- 239000011707 mineral Substances 0.000 claims description 11
- 235000010755 mineral Nutrition 0.000 claims description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 8
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 7
- 235000015872 dietary supplement Nutrition 0.000 claims description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 5
- 241001494501 Prosopis <angiosperm> Species 0.000 claims description 5
- 235000001560 Prosopis chilensis Nutrition 0.000 claims description 5
- 235000014460 Prosopis juliflora var juliflora Nutrition 0.000 claims description 5
- 229920000591 gum Polymers 0.000 claims description 5
- 239000000416 hydrocolloid Substances 0.000 claims description 5
- 229910000391 tricalcium phosphate Inorganic materials 0.000 claims description 5
- 229920002907 Guar gum Polymers 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 4
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 claims description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 4
- 125000000129 anionic group Chemical group 0.000 claims description 4
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 claims description 4
- 239000000292 calcium oxide Substances 0.000 claims description 4
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 claims description 4
- 235000010417 guar gum Nutrition 0.000 claims description 4
- 239000000665 guar gum Substances 0.000 claims description 4
- 229960002154 guar gum Drugs 0.000 claims description 4
- 229910052700 potassium Inorganic materials 0.000 claims description 4
- 235000010408 potassium alginate Nutrition 0.000 claims description 4
- 239000000737 potassium alginate Substances 0.000 claims description 4
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 claims description 4
- 239000000770 propane-1,2-diol alginate Substances 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 235000010413 sodium alginate Nutrition 0.000 claims description 4
- 239000000661 sodium alginate Substances 0.000 claims description 4
- 229920001285 xanthan gum Polymers 0.000 claims description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 3
- 229920000161 Locust bean gum Polymers 0.000 claims description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 3
- 239000001110 calcium chloride Substances 0.000 claims description 3
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 3
- 239000005018 casein Substances 0.000 claims description 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 3
- 235000021240 caseins Nutrition 0.000 claims description 3
- 229910052802 copper Inorganic materials 0.000 claims description 3
- 239000010949 copper Substances 0.000 claims description 3
- 229910052742 iron Inorganic materials 0.000 claims description 3
- 235000010420 locust bean gum Nutrition 0.000 claims description 3
- 239000000711 locust bean gum Substances 0.000 claims description 3
- 239000011777 magnesium Substances 0.000 claims description 3
- 229910052749 magnesium Inorganic materials 0.000 claims description 3
- 239000001814 pectin Substances 0.000 claims description 3
- 235000010987 pectin Nutrition 0.000 claims description 3
- 229920001277 pectin Polymers 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- MZYRDLHIWXQJCQ-YZOKENDUSA-L potassium alginate Chemical compound [K+].[K+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O MZYRDLHIWXQJCQ-YZOKENDUSA-L 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 235000010493 xanthan gum Nutrition 0.000 claims description 3
- 239000000230 xanthan gum Substances 0.000 claims description 3
- 229940082509 xanthan gum Drugs 0.000 claims description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 2
- 230000003750 conditioning effect Effects 0.000 claims description 2
- 239000000499 gel Substances 0.000 claims description 2
- 229910052740 iodine Inorganic materials 0.000 claims description 2
- 239000011630 iodine Substances 0.000 claims description 2
- 235000021056 liquid food Nutrition 0.000 claims description 2
- 239000011574 phosphorus Substances 0.000 claims description 2
- 229910052698 phosphorus Inorganic materials 0.000 claims description 2
- 235000018102 proteins Nutrition 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 239000011669 selenium Substances 0.000 claims description 2
- 229910052711 selenium Inorganic materials 0.000 claims description 2
- 235000013311 vegetables Nutrition 0.000 claims 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims 1
- 240000004246 Agave americana Species 0.000 claims 1
- 229960000583 acetic acid Drugs 0.000 claims 1
- 239000012362 glacial acetic acid Substances 0.000 claims 1
- 230000003389 potentiating effect Effects 0.000 claims 1
- 229940005550 sodium alginate Drugs 0.000 claims 1
- 238000005507 spraying Methods 0.000 claims 1
- 229920000642 polymer Polymers 0.000 abstract description 7
- 159000000007 calcium salts Chemical class 0.000 abstract description 4
- 238000009472 formulation Methods 0.000 abstract description 4
- 230000008569 process Effects 0.000 abstract description 4
- 150000003839 salts Chemical class 0.000 abstract description 4
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 abstract description 3
- 229910001424 calcium ion Inorganic materials 0.000 abstract description 3
- 239000002537 cosmetic Substances 0.000 abstract description 3
- 238000007614 solvation Methods 0.000 abstract description 2
- 239000013078 crystal Substances 0.000 abstract 1
- 230000008021 deposition Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 87
- 239000000047 product Substances 0.000 description 26
- 238000001228 spectrum Methods 0.000 description 17
- 230000006641 stabilisation Effects 0.000 description 14
- 238000011105 stabilization Methods 0.000 description 14
- 238000010521 absorption reaction Methods 0.000 description 9
- 238000000635 electron micrograph Methods 0.000 description 9
- 239000001506 calcium phosphate Substances 0.000 description 7
- 239000012530 fluid Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 230000000975 bioactive effect Effects 0.000 description 5
- 235000011010 calcium phosphates Nutrition 0.000 description 5
- 235000013361 beverage Nutrition 0.000 description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid group Chemical class C(CC(O)(C(=O)O)CC(=O)O)(=O)O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 229940072056 alginate Drugs 0.000 description 3
- 235000010443 alginic acid Nutrition 0.000 description 3
- 229920000615 alginic acid Polymers 0.000 description 3
- 229920006318 anionic polymer Polymers 0.000 description 3
- 229910000389 calcium phosphate Inorganic materials 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000000087 stabilizing effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 230000001143 conditioned effect Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- -1 for example Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000002366 mineral element Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 150000004044 tetrasaccharides Chemical class 0.000 description 2
- 229940078499 tricalcium phosphate Drugs 0.000 description 2
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- 239000004135 Bone phosphate Substances 0.000 description 1
- 240000008886 Ceratonia siliqua Species 0.000 description 1
- 235000013912 Ceratonia siliqua Nutrition 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 229940093761 bile salts Drugs 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 150000001669 calcium Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 235000021073 macronutrients Nutrition 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 239000011738 major mineral Substances 0.000 description 1
- 235000011963 major mineral Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 235000020786 mineral supplement Nutrition 0.000 description 1
- 229940029985 mineral supplement Drugs 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- 235000021055 solid food Nutrition 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A23L33/165—Complexes or chelates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
- C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
- C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/04—Alginic acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/06—Pectin; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L89/00—Compositions of proteins; Compositions of derivatives thereof
- C08L89/005—Casein
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/25—Exudates, e.g. gum arabic, gum acacia, gum karaya or tragacanth
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/275—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of animal origin, e.g. chitin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/15—Inorganic Compounds
- A23V2250/156—Mineral combination
- A23V2250/1578—Calcium
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
- C01F11/00—Compounds of calcium, strontium, or barium
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
- G01N2021/3595—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light using FTIR
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2223/00—Investigating materials by wave or particle radiation
- G01N2223/40—Imaging
- G01N2223/418—Imaging electron microscope
Definitions
- the present invention relates to a new methodology for stabilizing insoluble substances, such as tribasic calcium phosphate and calcium carbonate for absorption.
- insoluble substances such as tribasic calcium phosphate and calcium carbonate for absorption.
- insoluble calcium salts in cationic and ammonium polymers form soluble complexes, when the colloidal relationships are equimolar.
- the soluble calcium complex of the present invention has been formulated to Laboratory level using highly soluble natural fibers, such as chitosan, mesquite gum and fructans and inulin. Its stability during storage has been tested in acidic conditions at room temperature. This invention is based on generating and promoting the development of a new methodology to produce the soluble calcium complex.
- WO2007069072A2 it describes a food supplement based on mineral salts obtained with anions of organic or inorganic acids and metal cations such as calcium, magnesium, zinc, iron, copper, manganese, sodium, potassium, nickel or cobalt.
- Mineral salts are stabilized with amino acids and / or ammonium salts, stabilized between cationic bonds and dative covatent bonds.
- amino acids and metal cations such as calcium to carry out their respective biological functions once consumed in the food supplement, the dissociation of the compounds is required. So in this system a high energy expenditure is required to have free ions in an aqueous medium; For example, the energy required for calcium release is greater than 20 KJ / mol.
- US Patent 9,023,398 B describes a method for improving the solubility of poorly soluble substances such as tribasic calcium phosphate, for application in the Pharmaceutical, cosmetic, food and agriculture industry.
- the methods applied to improve the solubility include reducing the particle size to 100 ⁇ m or less, by mechanical methods.
- the reduction in particle size means an increase in surface area and an increase in contact with hydrophilic solutions; followed by physical coating using citric acid, citrate, phosphoric or chondroidin sulfate to enhance solubility.
- the process for supplying calcium as a dietary supplement is not specified.
- US 7,994,155 B2 describes an accelerator product for mineral absorption.
- the accelerator product is based on a non-reducing tetrasaccharide, composed of four glucose residues, cyclically linked via a-1, 3 and a-1, 6, cycle ⁇ > 6) -aD-glucopyranosyl- (1> 3) - aD-glucopyranosyl- (1> 6) -aD- glucopyranosyl- (1> 3) -a-Glucopyranosyl (1> ⁇ and / or saccharides derived therefrom.
- the main technological purpose has been the development of complex intermolecular systems, used as carrier vehicles capable of stabilizing and delivering bioactive compounds with multiple applications. Especially, because the properties of mono-molecular components are not sufficient to overcome the effects of different process or stability conditions. Fundamentally, because all those products that have the purpose of nourishing do not achieve the solvation process of multiple nutritional molecules. Challenge to be overcome, since 90% of the routes of administration is the oral route.
- a primary object of the present invention is to stabilize insoluble calcium salts in aqueous solutions and administer them as a food supplement or in food, pharmaceutical or cosmetic products.
- a stabilized soluble calcium complex consisting of a source of calcium present in an amount of 0.05 mg to 15 mg per gram of sample; a cationic polymer present in a mass proportion with respect to the calcium source between 0.25 and 12.5; an anionic hydrocololde; and a source of soluble fiber.
- a method for the preparation of the stabilized soluble calcium complex is also provided in accordance with the invention.
- the stabilized soluble calcium complexes referred to in the present finding mean application in the preparation of food supplements in liquid and / or solid form to be consumed either alone or in combination with solid foods, semi-solids, liquids, gels or beverages. . It also includes raw materials and intermediate products produced by any of the processing methods used in this procedure.
- the term "soluble calcium” referred to in the present finding means a complex composed of tribasic calcium phosphate or calcium chloride or calcium carbonate, or calcium ortho phosphate or calcium oxide; chitosan or protein of animal or plant origin; guar gum; Fructans and / or inulin. That can be used as an effective liquid or solid product to provide calcium and soluble fiber. To be administered alone or in the combinations referred to above.
- soluble minerals is referred to in the present invention, a required mineral, for example, calcium, phosphorus, iron, magnesium, potassium, copper, selenium and iodine.
- the mineral elements may be contained in the complex of the present finding.
- it contains alginate and its salts; sodium, potassium and propylene glycol alginate, mesquite gum, carob, xanthan, which function as carriers for the absorption of minerals in the living organism.
- the use of calcium is dependent on many factors, including: age, type of population, sex and health status. In addition to these factors, from the chemical point of view, the solubility and absorption is dependent on the structure of the sources used, ionization capacity, concentration of hydrogen ions available in the medium. Both factors modify the calcium absorption efficiency.
- One way to enhance the absorption of minerals, for example calcium, is to supply them in the form of ionized complexes in macromolecular systems such as that mentioned in this invention.
- Figure 1 Shows the average infrared electromagnetic spectrum of chitosan (- Q), gum arabic molecular weight (-GA), and tribasic calcium phosphate (-CP). Molecules used in the formation of soluble calcium using chitosan, gum arabic, fructans and / or inulin.
- Figure 2. Shows the mid-infrared electromagnetic spectrum of the 1.5 part soluble complex of tribasic calcium phosphate; 1 part chitosan; 20 parts of gum arabic; and 10 parts of fructans; and / or 5 parts defructans and 5 parts inulin, described in example 1.
- Figure 4 Shows the mid-infrared electromagnetic spectrum of the 5.0 part soluble complex of tribasic calcium phosphate; 1 part chitosan; 20 parts of gum arabic; 10 parts of fructans; or 5 parts fructans and 5 parts inulin, described in example 3.
- Figure 5 Shows an electron micrograph (2500X) of the soluble 1.5 part complex of tribasic calcium phosphate; 1 part chitosan; 20 parts of gum arabic; and 10 parts of fructans; 5 parts fructans and 5 parts of inulin, described in example 1 or 7.5 parts of fructans and 2.5 parts of inulin, soluble in water.
- Figure 6 Shows an electron micrograph (2500X) of the soluble 2.5 part complex of tribasic-chitosan calcium phosphate; 20 parts of gum arabic; and 10 parts of fructans; 5 parts of fructans and 5 parts inulin, described in example 2, soluble in water.
- Figure 7 Shows an electron micrograph (2500X) of the soluble complex of 5.0 parts of tribasic-chitosan calcium phosphate; 20 parts of gum arabic; and 10 parts of fructans; or 5 parts of fructans and 5 parts inulin, described in example 2, soluble in water.
- Figure 8. Shows the main steps for the preparation of soluble calcium, purpose of this invention.
- chitosan solution between 0.01 g to 4 g.
- step number one is mixed with the solution of step number two.
- the temperature is maintained between 1 ° C to 70 ° C, preferably at 30 ° C. Maintain the mass proportions between tribasic and chitosan calcium phosphate between 0.25 and 12.5, preferably 2.5.
- a food grade anionic hydrocolloid solution for example: gum arabic, guar gum, sodium or potassium alginate, propylene glycol alginate, mesquite gum, xanthan gum, locust bean gum, casein or pectin.
- Alginate and gum arabic between 0.01 g and 50 g.
- Example 1 Three parts of tribasic calcium phosphate are mixed with 10 parts phosphoric acid. The combination obtained is mixed with 89 parts of water. Tribasic calcium phosphate is integrated with the help of a mixer for 5 min. 100 parts of this example can be mixed with 80 parts of the solution prepared in example 3. Add in the solution obtained enough of a strong base to regulate the pH to 3.5. The prepared solution contains 666.7 mg of calcium in solution.
- the electromagnetic spectra shown in Figure 1 and Figure 2 show evidence of calcium stabilization at a ratio of 1.5 with respect to the cationic polymer used.
- Figure 2 contains chitosan, gum arabic, fructans and inulin.
- Example 2 Three parts of calcium carbonate are mixed with 12 parts of phosphoric acid. The combination obtained is mixed with 87 parts of water. Calcium carbonate is integrated with the help of a mixer for 5 min. 100 parts of this example can be mixed with 80 parts of the solution prepared in example 3. Add in the solution obtained enough of a strong base to regulate the pH to 3.5. The prepared solution contains 666.7 mg of calcium in solution.
- the electromagnetic spectra shown in Figure 1 and Figure 2 show evidence of calcium stabilization in a ratio of 1.5 with respect to the cationic polymer used.
- Figure 2 contains chitosan, gum arabic, fructans and inulin.
- Example 2 Mix 33 parts of the solution obtained with 13 parts of the solution obtained in example 3.
- the solution of example 2 is integrated with the aid of a mixer for 15 min. They will add the solution obtained, the amount Enough of a strong base to regulate the pH to 3.5.
- the solution can be integrated by heating at 60 ° C. Condition the solution obtained below 25 ° C.
- the solution obtained contains 860.8 mg of calcium in solution.
- the electromagnetic spectra shown in Figure 1 and Figure 3 show evidence of calcium stabilization at a ratio of 2.5 with respect to the cationic polymer used.
- Figure 2 contains chitosan, gum arabic, fructans and inulin.
- Example 8 a) Mix 5 parts of fructans with 50 parts of water. The solution obtained contains 10% of total apparent solids per 100 mL of solution. b) Mix 2.5 parts of inulin and 2.5 parts of fructans with 50 parts of water. The solution contains 10% of total apparent solids per 100 m of solution. c) Mix 1.25 parts of inulin and 3.75 parts of fructans with 50 parts of water. The solution contains 10% of total apparent solids per 100 m of solution. d) Mix 3.75 parts of inulin and 1.25 parts of fructans with 50 parts of water. The solution contains 10% of total apparent solids per 100 m of solution. e) Mix 5 parts of inulin are mixed with 50 parts of water. The solution obtained contains 10% of total apparent solids per 100 mL of solution.
- Example 9 20 parts of gum arabic are dispersed in 85 parts of water.
- the dispersion is conditioned for use in any of the examples, product of the invention. For example, mix 29.5 parts of the dispersion obtained in example 1 with 100 parts of this example. Add 50 parts of the solution obtained in example 8, subsection c). A fluid solution is obtained.
- the solution can be dried in the usual way to produce a fine powder.
- the product contains calcium and soluble fiber.
- the product can be applied in liquid form or solid dose.
- Example 12 Based on example 4, mix 46 parts with 100 parts of example 9. Add 50 parts of example 8, part d). A fluid solution is obtained. The solution can be dried in the usual way to produce a fine powder. The product contains calcium and soluble fiber. The product can be applied in liquid or solid form.
- the composition of the components, product of this invention is 3.75% tribasic calcium phosphate, 1.5% soluble calcium. 1.4% cationic polymer, 75.8% anionic polymer, 14.2% inulin and 4.7% fructans.
- the electromagnetic spectra shown in Figure 3 and the electron micrograph, shown in Figure 6 (2500X) show evidence of soluble calcium in a ratio of 2.5 with respect to the cationic polymer used.
- Example 13 Based on example 5, mix 46 parts with 100 parts of example 9. Add 50 parts of example 9, paragraph c). A fluid solution is obtained. The solution can be dried in the usual way to produce a fine powder. The product contains calcium and soluble fiber. The product can be applied in liquid or solid form.
- the composition of the components, product of this invention is 3.75% tribasic calcium phosphate, 1.5% soluble calcium. 1.4% cationic polymer, 75.8% ammonium polymer, 4.7% inulin and 14.2% fructans.
- the electromagnetic spectra shown in Figure 3 and the electron micrograph, shown in Figure 6 (2500X) show evidence of calcium stabilization at a ratio of 2.5 to the cationic polymer used.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- General Preparation And Processing Of Foods (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Jellies, Jams, And Syrups (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
Description
Claims
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201680059322.0A CN108135241A (zh) | 2015-10-15 | 2016-10-11 | 在阴离子阳离子聚合物和果聚糖中稳定的可溶性钙 |
BR112018007160A BR112018007160A2 (pt) | 2015-10-15 | 2016-10-11 | cálcio solúvel estabilizado em um polímero aniônico-catiôníco e frutanos. |
EP16855813.8A EP3363300A4 (en) | 2015-10-15 | 2016-10-11 | SOLUBLE CALCIUM STABILIZED IN ANIONIC CATIONIC-POLYMERIC POLYMER AND FRUCTANES |
US15/572,518 US10709160B2 (en) | 2015-10-15 | 2016-10-11 | Soluble calcium stabilised in an anionic-cationic polymer and fructans |
KR1020187010361A KR102431908B1 (ko) | 2015-10-15 | 2016-10-11 | 음이온성-양이온성 중합체 및 프룩탄 중에서 안정화된 가용성 칼슘 |
CA2985462A CA2985462C (en) | 2015-10-15 | 2016-10-11 | Soluble calcium stabilised in an anionic-cationic polymer and fructans |
JP2018518515A JP6764933B2 (ja) | 2015-10-15 | 2016-10-11 | アニオン性−カチオン性ポリマー及びフルクタン中で安定化された可溶性カルシウム |
HK18109628.1A HK1250565A1 (zh) | 2015-10-15 | 2018-07-25 | 在陰離子陽離子聚合物和果聚糖中穩定的可溶性鈣 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2015014522A MX2015014522A (es) | 2015-10-15 | 2015-10-15 | Calcio soluble estabilizado en polímero catiónico-polímero aniónico y fructanos. |
MXMX/A/2015/014522 | 2015-10-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2017065596A1 true WO2017065596A1 (es) | 2017-04-20 |
Family
ID=58518219
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/MX2016/000106 WO2017065596A1 (es) | 2015-10-15 | 2016-10-11 | Calcio soluble estabilizado en polímero catiónico-polímero aniónico y fructanos |
Country Status (10)
Country | Link |
---|---|
US (1) | US10709160B2 (es) |
EP (1) | EP3363300A4 (es) |
JP (1) | JP6764933B2 (es) |
KR (1) | KR102431908B1 (es) |
CN (1) | CN108135241A (es) |
BR (1) | BR112018007160A2 (es) |
CA (1) | CA2985462C (es) |
HK (1) | HK1250565A1 (es) |
MX (1) | MX2015014522A (es) |
WO (1) | WO2017065596A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114230685B (zh) * | 2021-12-21 | 2022-12-20 | 美泰科技(青岛)股份有限公司 | 一种具有抗骨质疏松功能的硫酸软骨素螯合钙的制备工艺 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1094919A (zh) * | 1993-05-13 | 1994-11-16 | 雷传喜 | 一种补钙饮料添加剂及其制备方法 |
US20030118712A1 (en) * | 2001-12-20 | 2003-06-26 | Navarro Y Koren Peter Antonio | Matrix-forming composition containing pectin |
EP1576895A1 (en) * | 2002-07-31 | 2005-09-21 | Maruo Calcium Company Limited | Food additive composition and food containing the same |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6207638B1 (en) * | 2000-02-23 | 2001-03-27 | Pacifichealth Laboratories, Inc. | Nutritional intervention composition for enhancing and extending satiety |
US6989166B2 (en) * | 2001-12-20 | 2006-01-24 | N.V. Nutricia | Soft drink replacer |
NL1019816C1 (nl) * | 2002-01-22 | 2003-07-23 | Adriaan Cornelis Kweldam | Kaasmelkeiwit vezel, met een nieuwe eigenschap, gebakken kaasvlees smelt niet, kaas wel. |
WO2005117607A2 (en) * | 2004-05-26 | 2005-12-15 | Cp Kelco U.S., Inc. | Calcium stable high acyl gellan gum for enhanced colloidal stability in beverages |
JP4484759B2 (ja) * | 2005-05-02 | 2010-06-16 | 森永製菓株式会社 | 高タンパクゲル状食品 |
US20070082028A1 (en) | 2005-10-07 | 2007-04-12 | Aimutis William R Jr | Compositions and methods for inducing satiety and reducing caloric intake |
AR055285A1 (es) | 2005-11-11 | 2007-08-15 | Edgardo Adrian Hager | Sales de nutrientes minerales estabilizados con aminoacidos productos y suplemento alimenticio que las comprenden y procedimientos de obtencion |
US20080069934A1 (en) * | 2006-09-18 | 2008-03-20 | ISON Renny | Cohesive non-free flowing sweetener compositions containing disintegrant |
KR101442069B1 (ko) | 2009-09-30 | 2014-09-18 | 가부시키가이샤 상기 | 난용성 물질의 수용해성 개선방법 |
WO2011138579A1 (en) * | 2010-05-05 | 2011-11-10 | St Giles Foods Limited | Edible compositions and methods of manufacturing edible compositions |
CN103483604A (zh) * | 2012-06-12 | 2014-01-01 | 江南大学 | 一种具有控释性的壳聚糖-结冷胶钙凝胶珠及其制备方法 |
JP5628355B2 (ja) | 2013-01-21 | 2014-11-19 | サンエイ糖化株式会社 | ミネラル吸収促進剤及び易吸収性カルシウム剤 |
-
2015
- 2015-10-15 MX MX2015014522A patent/MX2015014522A/es active IP Right Grant
-
2016
- 2016-10-11 EP EP16855813.8A patent/EP3363300A4/en active Pending
- 2016-10-11 WO PCT/MX2016/000106 patent/WO2017065596A1/es active Application Filing
- 2016-10-11 US US15/572,518 patent/US10709160B2/en active Active
- 2016-10-11 CA CA2985462A patent/CA2985462C/en active Active
- 2016-10-11 CN CN201680059322.0A patent/CN108135241A/zh active Pending
- 2016-10-11 KR KR1020187010361A patent/KR102431908B1/ko active IP Right Grant
- 2016-10-11 JP JP2018518515A patent/JP6764933B2/ja active Active
- 2016-10-11 BR BR112018007160A patent/BR112018007160A2/pt not_active Application Discontinuation
-
2018
- 2018-07-25 HK HK18109628.1A patent/HK1250565A1/zh unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1094919A (zh) * | 1993-05-13 | 1994-11-16 | 雷传喜 | 一种补钙饮料添加剂及其制备方法 |
US20030118712A1 (en) * | 2001-12-20 | 2003-06-26 | Navarro Y Koren Peter Antonio | Matrix-forming composition containing pectin |
EP1576895A1 (en) * | 2002-07-31 | 2005-09-21 | Maruo Calcium Company Limited | Food additive composition and food containing the same |
Non-Patent Citations (1)
Title |
---|
See also references of EP3363300A4 * |
Also Published As
Publication number | Publication date |
---|---|
JP6764933B2 (ja) | 2020-10-07 |
EP3363300A1 (en) | 2018-08-22 |
KR102431908B1 (ko) | 2022-08-11 |
CN108135241A (zh) | 2018-06-08 |
CA2985462C (en) | 2021-10-19 |
US10709160B2 (en) | 2020-07-14 |
KR20180067542A (ko) | 2018-06-20 |
EP3363300A4 (en) | 2019-08-07 |
MX2015014522A (es) | 2017-04-14 |
CA2985462A1 (en) | 2017-04-20 |
US20180116269A1 (en) | 2018-05-03 |
BR112018007160A2 (pt) | 2018-12-11 |
JP2018530339A (ja) | 2018-10-18 |
HK1250565A1 (zh) | 2018-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Skalickova et al. | Selenium nanoparticles as a nutritional supplement | |
ES2402215T3 (es) | Suspensión que contiene nanopartículas de ácido silícico coloidal estabilizadas con hidronio, formulación obtenida a partir de dicha suspensión diluida, polvo obtenido a partir de dicha suspensión deshidratada, composiciones obtenidas a partir de dicho polvo, preparación y uso | |
ES2453983T5 (es) | Control de la textura de composiciones nutricionales altas en proteínas que comprenden caseína micelar | |
JP2003504374A (ja) | クレアチンと必須金属とのバイオアベイラブルなキレート | |
JP2017512189A (ja) | 安定化されたポリマーのケイ酸塩組成物に関係する物質及び方法 | |
US8277848B2 (en) | Method for preparing aqueous solution of high-concentration calcium phosphate stable in neutral pH range | |
WO2017065596A1 (es) | Calcio soluble estabilizado en polímero catiónico-polímero aniónico y fructanos | |
EP2537424B1 (de) | Hochkalorische, proteinreiche enterale Sondennahrung | |
US20180193260A1 (en) | Beverage composition comprising nanoencapsulated oxygen | |
CN113876804B (zh) | 一种磷酸锰矿化药物纳米药物复合材料及其制备方法和应用 | |
CN109045278A (zh) | 一种稳定的乳蛋白质液态体系及其应用 | |
CN115052582A (zh) | 包含矿物质和/或维生素和多糖的制剂、其组合物及其在补充矿物质和/或维生素中的应用 | |
JP5956925B2 (ja) | カルシウム剤およびその製造方法 | |
US20140255465A1 (en) | Process For The Preparation Of A Non-Corrosive Base Solution And Methods Of Using Same | |
BR112016005727B1 (pt) | Uso de um extrato de polifenol de cacau para preparação de uma composição para tratamento de esofagite eosinofílica | |
Zeng et al. | One-pot approach to form in situ colchicine-containing nano-hydroxyapatite within microemulsion composite system for sustained transdermal delivery | |
KR101306931B1 (ko) | 골다공증 예방 효과를 가지는 유기태화 칼슘 강화 유단백질 | |
Zhang et al. | Multicompartmented nanostructures with tunable interior complexities co-assembled by two plant proteins | |
HRP20191040A2 (hr) | Formulacija stabilizirane ortho-silicijeve kiseline, njezina priprava i upotreba | |
CN104758313B (zh) | 一种磷酸盐复合粉剂 | |
BR102020019045A2 (pt) | Complexos de ferro nanoestruturados, processo de preparação de complexos de ferro nanoestruturados, composições contendo complexos de ferro nanoestruturados, seus usos e métodos de tratamento para prevenir e/ou tratar deficiências de ferro em humanos e animais | |
KR20200083971A (ko) | 칼슘 보충용 조성물 | |
HRP20140504A2 (hr) | Stabilizirana formulacija ortho-silicijeve kiseline, njezina priprava i upotreba | |
JPS58152820A (ja) | 癌治療用組成物 | |
CN106693073A (zh) | 镓掺杂的无定形磷酸钙生物活性纳米材料的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 16855813 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2985462 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 15572518 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2018518515 Country of ref document: JP |
|
ENP | Entry into the national phase |
Ref document number: 20187010361 Country of ref document: KR Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112018007160 Country of ref document: BR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2016855813 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 112018007160 Country of ref document: BR Kind code of ref document: A2 Effective date: 20180409 |